bibliographicCitation |
Fortunato O, Boeri M, Moro M, Verri C, Mensah M, Conte D, Caleca L, Roz L, Pastorino U, Sozzi G. Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction. Cell Death & Disease. 2014 Dec 11;5(12):e1564. doi: 10.1038/cddis.2014.507. |